Rakovina Therapeutics Stock Market Value
| RKV Stock | CAD 0.1 0.01 18.75% |
| Symbol | Rakovina |
Rakovina Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rakovina Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rakovina Therapeutics.
| 09/05/2024 |
| 12/04/2024 |
If you would invest 0.00 in Rakovina Therapeutics on September 5, 2024 and sell it all today you would earn a total of 0.00 from holding Rakovina Therapeutics or generate 0.0% return on investment in Rakovina Therapeutics over 90 days. Rakovina Therapeutics is related to or competes with Royal Bank, Toronto Dominion, Toronto Dominion, Amazon CDR, Bank of Nova Scotia, and Bank of Montreal. Certain Worldwide Rights of NewGen Therapeutics, Inc More
Rakovina Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rakovina Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rakovina Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.35 | |||
| Information Ratio | 0.0252 | |||
| Maximum Drawdown | 36.4 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 15.79 |
Rakovina Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rakovina Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rakovina Therapeutics' standard deviation. In reality, there are many statistical measures that can use Rakovina Therapeutics historical prices to predict the future Rakovina Therapeutics' volatility.| Risk Adjusted Performance | 0.039 | |||
| Jensen Alpha | 0.361 | |||
| Total Risk Alpha | (0.78) | |||
| Sortino Ratio | 0.0216 | |||
| Treynor Ratio | (0.57) |
Rakovina Therapeutics Backtested Returns
Rakovina Therapeutics appears to be out of control, given 3 months investment horizon. Rakovina Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0499, which implies the firm had a 0.0499% return per unit of risk over the last 3 months. We have found thirty technical indicators for Rakovina Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Rakovina Therapeutics' Semi Deviation of 6.07, coefficient of variation of 2548.14, and Risk Adjusted Performance of 0.039 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Rakovina Therapeutics holds a performance score of 3. The company holds a Beta of -0.54, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Rakovina Therapeutics are expected to decrease at a much lower rate. During the bear market, Rakovina Therapeutics is likely to outperform the market. Please check Rakovina Therapeutics' treynor ratio and the relationship between the semi variance and price action indicator , to make a quick decision on whether Rakovina Therapeutics' historical price patterns will revert.
Auto-correlation | -0.24 |
Weak reverse predictability
Rakovina Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Rakovina Therapeutics time series from 5th of September 2024 to 20th of October 2024 and 20th of October 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rakovina Therapeutics price movement. The serial correlation of -0.24 indicates that over 24.0% of current Rakovina Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | 0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Rakovina Therapeutics lagged returns against current returns
Autocorrelation, which is Rakovina Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rakovina Therapeutics' stock expected returns. We can calculate the autocorrelation of Rakovina Therapeutics returns to help us make a trade decision. For example, suppose you find that Rakovina Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rakovina Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rakovina Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rakovina Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rakovina Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Rakovina Therapeutics Lagged Returns
When evaluating Rakovina Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rakovina Therapeutics stock have on its future price. Rakovina Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rakovina Therapeutics autocorrelation shows the relationship between Rakovina Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Rakovina Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rakovina Stock Analysis
When running Rakovina Therapeutics' price analysis, check to measure Rakovina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rakovina Therapeutics is operating at the current time. Most of Rakovina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rakovina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rakovina Therapeutics' price. Additionally, you may evaluate how the addition of Rakovina Therapeutics to your portfolios can decrease your overall portfolio volatility.